Regeneron Pharmaceuticals Inc REGN:NASDAQ

Last Price$512.96NASDAQ Closing Price as of 3:59PM ET 4/09/20

Today's Change+0.63(0.12%)
Bid (Size)$512.60 (1)
Ask (Size)$518.00 (1)
Day Low / High$500.87 - 515.64
Volume1.0 M
 

View Biotechnology IndustryPeer Comparison as of 04/09/2020

 

Regeneron Pharmaceuticals Inc ( NASDAQ )

Price: $512.96
Change: +0.63 (0.12%)
Volume: 1.0 M
3:59PM ET 4/09/2020
 
 

Biogen Inc ( NASDAQ )

Price: $321.05
Change: +4.10 (1.29%)
Volume: 1.5 M
4:00PM ET 4/09/2020
 
 

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A
N/A
 
 

Vertex Pharmaceuticals Inc ( NASDAQ )

Price: $246.61
Change: -3.05 (1.22%)
Volume: 2.5 M
4:00PM ET 4/09/2020
 
 

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A
N/A
 

Read more news Recent News

Insider Trends: Regeneron Pharmaceuticals Insider Exercises Options Derivative Securities, Sells for Taxes and Self, Selling Trend Unaffected
4:05PM ET 4/08/2020 MT Newswires

On Apr 06, 2020, EVP Finance CFO, Robert E Landry, exercised options/derivative securities for 3,000 shares. A portion of these optioned shares (2,304...

--Analyst Actions: Benchmark Capital Initiates Regeneron Pharmaceuticals at Hold
8:34AM ET 4/08/2020 MT Newswires

Price: 506.00, Change: +4.49, Percent Change: +0.90 ...

Regeneron Grants Zai Lab Rights to Develop, Commercialize Lymphoma Drug in China, Hong Kong, Taiwan, Macau
6:43AM ET 4/08/2020 MT Newswires

Regeneron Pharmaceuticals (REGN), a US biotech firm, and Zai Lab (ZLAB), a Chinese commercial-stage biopharmaceutical company, said Wednesday that Zai Lab...

Regeneron Pharmaceuticals, Sanofi Restructure Agreement for Praluent
11:07AM ET 4/07/2020 MT Newswires

Regeneron Pharmaceuticals (REGN) said Tuesday that it has restructured its Praluent (alirocumab) agreement with partner Sanofi (SNY), which is expected to...

View all Commentary and Analysis

Stock Market's Next Move
3:00PM ET 4/09/2020 Seeking Alpha

Coronavirus Testing, Vaccines & Treatments: What You Should Know
2:48PM ET 4/09/2020 Zacks

We discuss latest developments in tests, vaccines and therapies for COVID-19.

Coronavirus Testing, Vaccines & Treatments: What You Should Know
2:48PM ET 4/09/2020 Zacks

We discuss latest developments in tests, vaccines and therapies for COVID-19.

Gilead's Path To COVID-19 Market Dominance
4:06PM ET 4/07/2020 Seeking Alpha

Company Profile

Business DescriptionRegeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. View company web site for more details
Address777 Old Saw Mill River Road
Tarrytown, New York 10591-6707
Phone+1.914.847.7000
Number of Employees7,400
Recent SEC Filing04/08/20204
Co-President, Chief Executive Officer & DirectorLeonard S. Schleifer
Co-President, Director & Chief Scientific OfficerGeorge Damis Yancopoulos
Chief Financial Officer & Executive VP-FinanceRobert E. Landry
Executive VP-Research & DevelopmentNeil Stahl

Company Highlights

Price Open$510.10
Previous Close$512.33
52 Week Range$271.37 - 518.00
Market Capitalization$55.5 B
Shares Outstanding108.2 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement05/05/2020

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share$17.75
Beta vs. S&P 500N/A
Revenue$6.7 B
Net Profit Margin26.91%
Return on Equity20.75%

Analyst Ratings as of 04/07/2020

Buy
12
Overweight
1
Hold
13
Underweight
1
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset